After the trial ends, the investigators will begin to analyze the data that has been collected during the trial. They will write up reports about what they have found and submit them to a treatment-approving agency, such as the FDA. The agency will make decisions about whether the treatment will move further into other trials, or whether it will be approved.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?